Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/2000
03/16/2000CA2309212A1 Essential bacterial genes and their use
03/15/2000EP0986164A1 Brush holder
03/15/2000EP0985415A1 Uracil reductase inactivators
03/15/2000EP0985053A1 Translational frameshift based drug screening assay
03/15/2000EP0985038A1 Sodium channel receptor
03/15/2000EP0985036A1 Zinc ring protein
03/15/2000EP0985032A1 RIBOSOME COMPLEXES AS SELECTION PARTICLES FOR $i(IN VITRO) DISPLAY AND EVOLUTION OF PROTEINS
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984789A2 Accelerating animal hoof growth with somatotropin
03/15/2000EP0984784A2 Anti-cancer products for treating cystic fibrosis
03/15/2000EP0984699A1 Method of inhibiting immune system destruction of transplanted viable cells
03/15/2000EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS
03/15/2000EP0550580B1 Uracil reductase inactivator
03/15/2000EP0549702B1 Use of recombinant colony stimulating factor-1
03/15/2000CN1247472A Treatment of lupus nephritis with anti-CD40L compounds
03/14/2000US6037481 Process for stabilizing levogyre ascorbic acid (LAA), a stable aqueous LAA composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment
03/14/2000US6037386 Latex barrier having polymer matrix comprising zinc oxide or zinc gluconate gel irritant deactivating agent; condoms, gloves
03/14/2000US6037376 Methods for therapy of cancer
03/14/2000US6037360 Side effect reduction; treating sexual disorders
03/14/2000US6037357 Antitumor and antimetastasis agents
03/14/2000US6037348 Inhibition of viral replication
03/14/2000US6037347 Comprising a compound which has an acetylcholinesterase-inhibitory action or exhibits muscarinergic action and a compound which increases the endogenous extracellular adenosine level
03/14/2000US6037346 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
03/14/2000US6037331 Compositions for prevention of inflammation and adhesion formation uses thereof
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6036973 Therapy for neurological diseases
03/14/2000US6036954 Polypeptides with sequence
03/14/2000CA2123593C Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
03/14/2000CA2013188C Preservative system for ophthalmic formulations
03/09/2000WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012703A2 Protein transport-associated molecules
03/09/2000WO2000012702A2 Human genes differentially expressed in colorectal cancer
03/09/2000WO2000012679A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000WO2000012587A2 Polyamide chains of precise length, methods to manufacture them and their conjugates
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012549A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000WO2000012544A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012532A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012525A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000WO2000012516A1 Phosphohalohydrins, method for making same and uses
03/09/2000WO2000012140A1 Method for labeling biopolymers using isotopes
03/09/2000WO2000012139A1 Hypoxia regulated genes
03/09/2000WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012111A2 Selective treatment of endothelial somatostatin receptors
03/09/2000WO2000012110A2 Use of anti(w)pressor agents for vascular remodeling in genital dysfunction
03/09/2000WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000012099A1 Promoters of neural regeneration
03/09/2000WO2000012093A1 Method of treating neurodegenerative diseases
03/09/2000WO2000012086A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000WO2000012080A1 Diet composition and method of weight management
03/09/2000WO2000012078A1 Therapies for treating pulmonary diseases
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012073A1 Use of 5ht-6 antagonists
03/09/2000WO2000012072A2 The use of fumaric acid derivatives in transplant medicine
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000WO2000012048A2 Carbapenem antibacterial compositions and methods of treatment
03/09/2000WO2000012047A2 Enhancement of return to independent living status with a growth hormone secretagogue
03/09/2000WO2000001377A3 Nalmefene in combination with opioid analgesics
03/09/2000WO1999065515A3 Combination of radiotherapy and anti-angiogenic factors
03/09/2000WO1999064570A9 Novel methods and interferon deficient substrates for the propagation of viruses
03/09/2000WO1999064068A9 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
03/09/2000WO1999061590A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000WO1999051215A3 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
03/09/2000WO1999020260A3 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
03/09/2000WO1998052600A9 Methods of enhancing functioning of the upper gastrointestinal tract
03/09/2000DE19840731A1 Zwei Farben Differential Display als Verfahren zur Detektion regulierter Gene Two colors as differential display method for detecting regulated genes
03/09/2000DE19839566A1 Verwendung von Fumarsäurederivaten in der Transplantationsmedizin Use of fumaric acid derivatives in transplantation
03/09/2000CA2351739A1 Polyamide chains of precise length, methods to manufacture them and their conjugates with proteins
03/09/2000CA2342534A1 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000CA2342350A1 Promoters of neural regeneration
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2341705A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000CA2341650A1 Carbapenem antibacterial compositions and methods of treatment
03/09/2000CA2341649A1 Enhancement of return to independent living status with a growth hormone secretagogue
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/09/2000CA2341518A1 Hypoxia regulated genes
03/09/2000CA2341488A1 Therapies for treating pulmonary diseases
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341064A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2340885A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000CA2340796A1 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340206A1 Use of anti-pressor agents for vascular remodeling in genital dysfunction
03/09/2000CA2339947A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000CA2339140A1 Method of treating neurodegenerative diseases
03/09/2000CA2337869A1 Method for labeling biopolymers using isotopes
1 ... 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 ... 1151